dacuronium has been researched along with pancuronium in 16 studies
| Studies (dacuronium) | Trials (dacuronium) | Recent Studies (post-2010) (dacuronium) | Studies (pancuronium) | Trials (pancuronium) | Recent Studies (post-2010) (pancuronium) |
|---|---|---|---|---|---|
| 17 | 8 | 0 | 2,188 | 345 | 48 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (31.25) | 18.7374 |
| 1990's | 6 (37.50) | 18.2507 |
| 2000's | 5 (31.25) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Agoston, S; Crul, EJ; Houwertjes, MC; Kersten, UW; Scaf, AH | 1 |
| Baden, JM | 1 |
| Fotherby, K | 1 |
| Chen, JK; Fan, BC; Fotherby, K; He, ML; Li, LM; Rekers, H; Song, S; Yang, PJ | 1 |
| Barjaktarović, N; Lukić, B | 1 |
| Booij, LH; Crul, JE; Vree, TB | 1 |
| Fioretti, P; Kirkman, RJ; Pedersen, JH; Roberts, HE | 1 |
| Akerlund, M; Røde, A; Westergaard, J | 1 |
| Basdevant, A; Conard, J; Degrelle, H; Guy-Grand, B; Guyene, TT; Lapousterle, C; Mayer, M; Pelissier, C | 1 |
| Borm, GF; Coenen, CM; Hollanders, JM; Rolland, R; Thomas, CM | 1 |
| de Man, RA; Janssen, HL; Minnema, MC; Niermeijer, P | 1 |
| Baranowski, W; Bogusiewicz, M; Jakimiuk, AJ; Jakowicki, JA; Kulik-Rechberger, B; Postawski, K; Rechberger, T; Tomaszewski, J | 1 |
| Ledzhev, I; Malinova, M; Pekhlivanov, B; Uchikova, E | 1 |
| Bischof, P; de Ziegler, D; Fraisse, T; Ibecheole, V; Pillet, C; Streuli, I | 1 |
| Choi, D; Choi, J; Koo, YA; Lee, B; Lee, E; Park, HJ | 1 |
2 review(s) available for dacuronium and pancuronium
| Article | Year |
|---|---|
Clinical experience and pharmacological effects of an oral contraceptive containing 20 micrograms oestrogen.
Topics: Adult; Blood Proteins; Carbohydrate Metabolism; Clinical Trials as Topic; Female; Humans; Lipid Metabolism; Ovary; Pancuronium; Pituitary Gland | 1992 |
Org-NC45: a new steroidal non-depolarizing muscle relaxant.
Topics: Humans; Neuromuscular Nondepolarizing Agents; Pancuronium; Tubocurarine; Vecuronium Bromide | 1982 |
8 trial(s) available for dacuronium and pancuronium
| Article | Year |
|---|---|
A cross-over study of three oral contraceptives containing ethinyloestradiol and either desogestrel or levonorgestrel.
Topics: Adult; Apolipoproteins; Blood Glucose; Ceruloplasmin; Cholesterol; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Ethinyl Estradiol-Norgestrel Combination; Female; Glucose Tolerance Test; Humans; Insulin; Levonorgestrel; Lipids; Norgestrel; Norpregnenes; Pancuronium; Progesterone Congeners; Sex Hormone-Binding Globulin; Testosterone; Triglycerides | 1992 |
Clinical comparison of two low-dose oral contraceptives, Minulet and Mercilon, in women over 30 years of age.
Topics: Adult; Contraceptives, Oral, Combined; Denmark; Ethinyl Estradiol; Female; Humans; Italy; Middle Aged; New Zealand; Norpregnenes; Pancuronium; United Kingdom | 1994 |
Comparative profiles of reliability, cycle control and side effects of two oral contraceptive formulations containing 150 micrograms desogestrel and either 30 micrograms or 20 micrograms ethinyl oestradiol.
Topics: Adolescent; Adult; Body Weight; Chemistry, Pharmaceutical; Contraceptives, Oral, Combined; Desogestrel; Double-Blind Method; Ethinyl Estradiol; Female; Humans; Menstrual Cycle; Pancuronium; Risk Factors | 1993 |
Hemostatic and metabolic effects of lowering the ethinyl-estradiol dose from 30 mcg to 20 mcg in oral contraceptives containing desogestrel.
Topics: Apolipoprotein A-I; Cholesterol, HDL; Contraceptives, Oral, Hormonal; Desogestrel; Dose-Response Relationship, Drug; Ethinyl Estradiol; Female; Hemostasis; Humans; Pancuronium; Plasminogen; Prospective Studies; Protein C; Protein S; Renin; Sex Hormone-Binding Globulin; Transcortin; Triglycerides | 1993 |
Changes in androgens during treatment with four low-dose contraceptives.
Topics: 17-alpha-Hydroxyprogesterone; Adolescent; Adult; Androgens; Androstenedione; Contraceptives, Oral, Combined; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Desogestrel; Dihydrotestosterone; Drug Combinations; Ethinyl Estradiol; Ethinyl Estradiol-Norgestrel Combination; Female; Humans; Hydroxyprogesterones; Luteal Phase; Norgestrel; Norpregnenes; Pancuronium; Progestins; Sex Hormone-Binding Globulin; Testosterone; Transcortin | 1996 |
Serum concentrations of markers of type I collagen metabolism in women taking monophasic oral contraceptives.
Topics: Adult; Biomarkers; Collagen Type I; Contraceptives, Oral, Synthetic; Desogestrel; Female; Humans; Pancuronium; Peptide Fragments; Peptides; Procollagen | 2002 |
[Hemostatic profile of women using low-dose oral contraceptive Mercilon. (Preliminary report)].
Topics: Adolescent; Adult; Contraceptives, Oral; Female; Hemostasis; Humans; Pancuronium | 2002 |
Serum antimüllerian hormone levels remain stable throughout the menstrual cycle and after oral or vaginal administration of synthetic sex steroids.
Topics: Administration, Intravaginal; Adult; Anti-Mullerian Hormone; Contraceptive Agents, Female; Contraceptives, Oral, Hormonal; Desogestrel; Drug Combinations; Ethinyl Estradiol; Female; Humans; Menstrual Cycle; Pancuronium | 2008 |
6 other study(ies) available for dacuronium and pancuronium
| Article | Year |
|---|---|
The relationship between disposition and duration of action of congeneric series of steroidal neuromuscular blocking agents.
Topics: Animals; Cats; Chromatography, Thin Layer; Female; Fluorometry; Injections, Intra-Arterial; Injections, Intravenous; Kidney; Liver; Male; Muscles; Neuromuscular Blocking Agents; Pancuronium; Time Factors | 1977 |
Anticholinergic actions of steroid muscle relaxants.
Topics: Acetylcholine; Androstane-3,17-diol; Animals; Dose-Response Relationship, Drug; Heart Rate; Muscle Relaxants, Central; Pancuronium; Parasympatholytics; Rabbits | 1976 |
Mercilon--a new low-dose combined oral contraceptive.
Topics: Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Female; Humans; Norpregnenes; Pancuronium; Progesterone Congeners | 1989 |
Sister-chromatid exchanges in newborns after normal and progesterone-treated pregnancies.
Topics: DNA Damage; Female; Humans; Infant, Newborn; Lymphocytes; Maternal-Fetal Exchange; Pancuronium; Pregnancy; Pregnancy Complications; Progesterone; Sister Chromatid Exchange | 1987 |
Budd-Chiari syndrome: combination of genetic defects and the use of oral contraceptives leading to hypercoagulability.
Topics: Adolescent; Budd-Chiari Syndrome; Contraceptives, Oral; Factor V; Female; Hepatomegaly; Humans; Mutation; Pancuronium; Prothrombin; Risk Factors; Thrombophilia; Tomography, X-Ray Computed | 2000 |
Altered vascular endothelial growth factor expression during GnRH antagonist protocol in women of reproductive age with normal baseline hormone profiles.
Topics: Adult; Chorionic Gonadotropin; Estradiol; Female; Fertility Agents, Female; Fertilization in Vitro; Follicle Stimulating Hormone, Human; Follicular Fluid; Gonadotropin-Releasing Hormone; Hormone Antagonists; Hormones; Humans; Luteinizing Hormone; Oocyte Retrieval; Ovulation Induction; Pancuronium; Pregnancy; Pregnancy Rate; Progesterone; Retrospective Studies; Treatment Outcome; Vascular Endothelial Growth Factor A | 2009 |